Reading on the web. Open in the Thier app for the full interactive version, progress tracking, and XP.
Open

ApoB — The Particle Count

1-minute read 25 XP in app 6 cards

One molecule per atherogenic particle

Apolipoprotein B (ApoB) is a surface protein on every atherogenic particle — LDL, VLDL, IDL, Lp(a), chylomicron remnants. There's exactly one ApoB per particle, so measuring ApoB measures particle count directly. It's the cleanest single number we have for cardiovascular risk.

1:1 ApoB to atherogenic particle
Fact

Lower is better — much lower than most people think

Attia, Dayspring, and the preventive-cardiology world target ApoB under 60 mg/dL for aggressive prevention, under 80 mg/dL for average risk. Guideline targets are still creeping down from 100+ historical numbers as trials show cumulative exposure drives plaque formation over decades.

< 60 mg/dL aggressive target
Fact

Cumulative ApoB burden predicts disease

It's not your ApoB today — it's your ApoB × years of exposure. Someone with ApoB 120 for 40 years accumulates double the arterial burden of someone with ApoB 60 for the same time. Early intervention compounds hugely, which is why checking ApoB in your 30s matters.

× years cumulative exposure
Try in app

Order the ApoB target tiers

Drag these targets from most to least aggressive.

This step is hands-on. Open the Thier app to try the full interaction.
Insight

The test costs nothing extra

ApoB is on most lab menus, usually $5–15, usually covered when ordered. The reason most doctors don't order it isn't cost — it's inertia. If you ask for it you'll generally get it. Most of preventive cardiology is now structured around this number.

$5–15 test cost
Takeaway

Key Takeaway

ApoB is the single best cardiovascular-risk number on a standard lab panel. Your cumulative ApoB exposure over decades shapes your arterial health far more than any single reading. Get the test, track it annually, act when it's elevated.

References

  1. ApoB-lowering for CVD prevention — Mendelian randomisation + meta-analysisFerence et al., 2019
  2. Cumulative exposure to ApoB and coronary artery disease — genetic evidenceFerence et al., 2017

Track your progress

Read the cards above, then mark this lesson complete to track your progress.
Open in app for XP
Up next

Lp(a) — The Hidden Risk